Prev：ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling(A21020-7)
Next：RPL9 acts as an oncogene by shuttling miRNAs through exosomes in human hepatocellular carcinoma cells(A25012-4.9)
